Inverse agonism and neutral antagonism at cannabinoid CB1 receptors

Life Sciences

Volumn 76, Issue 12, 2005, Pages 1307-1324

  Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

AM251; AM281; Anandamide; Autoprotection; CB1 receptors; Endocannabinoids; Inverse agonism; LY320135; Neutral antagonists; SR141716A

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; ADENOSINE; ADENOSINE A1 RECEPTOR; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; LIGAND; RIMONABANT;

ALLOSTERISM; BIOASSAY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 12744258029     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.10.025     Document Type: Short Survey

References (110)

1. N. Auclair, S. Otani, P. Soubrié, and F. Crepel Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons Journal of Neurophysiology 83 6 2000 3287 3293
2. D. Baker, G. Pryce, J.L. Croxford, P. Brown, R.G. Pertwee, J.W. Huffman, and L. Layward Cannabinoids control spasticity and tremor in a multiple sclerosis model Nature 404 6773 2000 84 87
3. D. Baker, G. Pryce, J.L. Croxford, P. Brown, R.G. Pertwee, A. Makriyannis, A. Khanolkar, L. Layward, F. Fezza, T. Bisogno, and V. Di Marzo Endocannabinoids control spasticity in a multiple sclerosis model FASEB Journal 15 2001 300 302
4. C.E. Bass, G. Griffin, M. Grier, A. Mahadevan, R.K. Razdan, and B.R. Martin SR-141716A-induced stimulation of locomotor activity: a structure-activity relationship study Pharmacology Biochemistry and Behavior 74 1 2002 31 40
5. M. Begg, A. Molleman, and M. Parsons Modulation of the release of endogenous γ-aminobutyric acid by cannabinoids in the guinea pig ileum European Journal of Pharmacology 434 1-2 2002 87 94
6. E.M. Berry, and R. Mechoulam Tetrahydrocannabinol and endocannabinoids in feeding and appetite Pharmacology & Therapeutics 95 2 2002 185 190
7. M. Bouaboula, S. Perrachon, L. Milligan, X. Canat, M. Rinaldi-Carmona, M. Portier, F. Barth, B. Calandra, F. Pecceu, J. Lupker, J.-P. Maffrand, G. Le Fur, and P. Casellas A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions Journal of Biological Chemistry 272 35 1997 22330 22339
8. C.S. Breivogel, G. Griffin, V. Di Marzo, and B.R. Martin Evidence for a new G protein-coupled cannabinoid receptor in mouse brain Molecular Pharmacology 60 1 2001 155 163
9. C.S. Breivogel, J.M. Walker, S.M. Huang, M.B. Roy, and S.R. Childers Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids Neuropharmacology 47 1 2004 81 91
10. 1 receptor antagonist, SR 141716 (Rimonabant) European Journal of Pharmacology 494 2-3 2004 221 224
11. 1 receptors in the mouse gastroenteric tract Eur. J. Pharmacol. 459 1 2003 97 105
12. A.T. Chaytor, P.E.M. Martin, W.H. Evans, M.D. Randall, and T.M. Griffith The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication Journal of Physiology 520 2 1999 539 550
13. J.F. Cheer, D.A. Kendall, and C.A. Marsden Cannabinoid receptors and reward in the rat: a conditioned place preference study Psychopharmacology 151 1 2000 25 30
14. A. Christopoulos, P. Coles, L. Lay, M.J. Lew, and J.A. Angus Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens British Journal of Pharmacology 132 6 2001 1281 1291
15. G. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G.L. Gessa Appetite suppression and weight loss after the cannabinoid antagonist SR141716 Life Sciences 63 8 1998 PL113 PL117
16. G. Colombo, R. Agabio, C. Lobina, R. Reali, and G.L. Gessa Cannabinoid modulation of intestinal propulsion in mice European Journal of Pharmacology 344 1 1998 67 69
17. 9-tetrahydrocannabinol-induced responses and apparent agonist activity Journal of Pharmacology and Experimental Therapeutics 277 2 1996 586 594
18. M. Cosenza, A.N. Gifford, S.J. Gatley, B. Pyatt, Q. Liu, A. Makriyannis, and N.D. Volkow Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281 Synapse 38 4 2000 477 482
19. B. Costa, and M. Colleoni SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists Acta Pharmacologica Sinica 20 12 1999 1103 1108
20. A.A. Coutts, N. Brewster, T. Ingram, R.K. Razdan, and R.G. Pertwee Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine British Journal of Pharmacology 129 4 2000 645 652
21. A.A. Coutts, and R.G. Pertwee Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus British Journal of Pharmacology 121 8 1997 1557 1566
22. 1 receptor antagonist/inverse agonist SR 141716A Neuropsychopharmacology 24 2 2001 198 203
23. L. De Petrocellis, T. Bisogno, M. Maccarrone, J.B. Davis, A. Finazzi-Agrò, and V. Di Marzo The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism Journal of Biological Chemistry 276 16 2001 12856 12863
24. L. De Petrocellis, M.G. Cascio, and V. Di Marzo The endocannabinoid system: a general view and latest additions British Journal of Pharmacology 141 5 2004 765 774
25. J. De Vry, R. Schreiber, G. Eckel, and K.R. Jentzsch Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A European Journal of Pharmacology 483 1 2004 55 63
26. V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Bátkai, Z. Járai, F. Fezza, G.I. Miura, R.D. Palmiter, T. Sugiura, and G. Kunos Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 6830 2001 822 825
27. C.C. Felder, K.E. Joyce, E.M. Briley, M. Glass, K.P. Mackie, K.J. Fahey, G.J. Cullinan, D.C. Hunden, D.W. Johnson, M.O. Chaney, G.A. Koppel, and M. Brownstein LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation Journal of Pharmacology and Experimental Therapeutics 284 1 1998 291 297
28. C.S. Freedland, J.S. Poston, and L.J. Porrino Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding Pharmacology, Biochemistry and Behavior 67 2 2000 265 270
29. 9-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors Neuroscience Letters 226 3 1997 159 162
30. E. Fride, Y. Ginzburg, A. Breuer, T. Bisogno, V. Di Marzo, and R. Mechoulam Critical role of the endogenous cannabinoid system in mouse pup suckling and growth European Journal of Pharmacology 419 2-3 2001 207 214
31. G.L. Gessa, M.A. Casu, G. Carta, and M.S. Mascia Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A European Journal of Pharmacology 355 2-3 1998 119 124
32. G.L. Gessa, M.S. Mascia, M.A. Casu, and G. Carta Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A European Journal of Pharmacology 327 1 1997 R1 R2
33. A.N. Gifford, M. Bruneus, S.J. Gatley, and N.D. Volkow Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes British Journal of Pharmacology 131 3 2000 645 650
34. A.N. Gifford, Y. Tang, S.J. Gatley, N.D. Volkow, R. Lan, and A. Makriyannis Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices Neuroscience Letters 238 1-2 1997 84 86
35. N. Hájos, and T.F. Freund Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers Neuropharmacology 43 4 2002 503 510
36. N. Hájos, C. Ledent, and T.F. Freund Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus Neuroscience 106 1 2001 1 4
37. U. Herzberg, E. Eliav, G.J. Bennett, and I.J. Kopin The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neuroscience Letters 221 2-3 1997 157 160
38. 9-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716 Psychopharmacology 165 4 2003 370 377
39. 1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity FEBS Letters 459 2 1999 277 281
40. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International Union of Pharmacology: XXVII. Classification of cannabinoid receptors Pharmacological Reviews 54 2 2002 161 202
41. C.-C. Huang, S.-W. Lo, and K.-S. Hsu Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons Journal of Physiology 532 3 2001 731 748
42. D.P. Hurst, D.L. Lynch, J. Barnett-Norris, S.M. Hyatt, H.H. Seltzman, M. Zhong, Z.-H. Song, J. Nie, D. Lewis, and P.H. Reggio N-(Piperidin-1-yl)-5-(4- chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor Molecular Pharmacology 62 6 2002 1274 1287
43. A.A. Izzo, F. Capasso, A. Costagliola, T. Bisogno, G. Marsicano, A. Ligresti, I. Matias, R. Capasso, L. Pinto, F. Borrelli, A. Cecio, B. Lutz, N. Mascolo, and V. Di Marzo An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice Gastroenterology 125 3 2003 765 774
44. 1 receptors British Journal of Pharmacology 124 7 1998 1363 1368
45. 1 receptors Naunyn-Schmiedebergs Archives of Pharmacology 359 1 1999 65 70
46. A.A. Izzo, N. Mascolo, L. Pinto, R. Capasso, and F. Capasso The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats European Journal of Pharmacology 384 1 1999 37 42
47. 1 ligands in the isolated guinea-pig ileum British Journal of Pharmacology 129 5 2000 984 990
48. Z. Járai, J.A. Wagner, K. Varga, K.D. Lake, D.R. Compton, B.R. Martin, A.M. Zimmer, T.I. Bonner, N.E. Buckley, E. Mezey, R.K. Razdan, A. Zimmer, and G. Kunos Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proceedings of the National Academy of Sciences of the United States of America 96 24 1999 14136 14141
49. 1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain Naunyn-Schmiedebergs Archives of Pharmacology 359 6 1999 466 470
50. 1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice Naunyn-Schmiedebergs Archives of Pharmacology 363 1 2001 50 56
51. C.S. Kearn, M.J. Greenberg, R. DiCamelli, K. Kurzawa, and C.J. Hillard Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange Journal of Neurochemistry 72 6 1999 2379 2387
52. A.C. Kreitzer, and W.G. Regehr Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells Neuron 29 3 2001 717 727
53. R.S. Landsman, T.H. Burkey, P. Consroe, W.R. Roeske, and H.I. Yamamura SR141716A is an inverse agonist at the human cannabinoid CB1 receptor European Journal of Pharmacology 334 1 1997 R1 R2
54. W. Lang, C. Qin, S. Lin, A.D. Khanolkar, A. Goutopoulos, P. Fan, K. Abouzid, Z. Meng, D. Biegel, and A. Makriyannis Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase Journal of Medicinal Chemistry 42 5 1999 896 902
55. G. Le Fur Clinical results with rimonabant in obesity Symposium on the Cannabinoids 2004 International Cannabinoid Research Society Burlington, Vermont 67
56. P. Leff The two-state model of receptor activation Trends in Pharmacological Sciences 16 3 1995 89 97
57. C. Liao, J. Zheng, L.S. David, and R.A. Nicholson Inhibition of voltage-sensitive sodium channels by the cannabinoid 1 receptor antagonist AM 251 in mammalian brain Basic and Clinical Pharmacology & Toxicology 94 2 2004 73 78
58. A.H. Lichtman SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats European Journal of Pharmacology 404 1-2 2000 175 179
59. 2 receptors British Journal of Pharmacology 124 4 1998 619 622
60. R. Mancinelli, A. Fabrizi, S. Del Monaco, G.B. Azzena, R. Vargiu, G.C. Colombo, and G.L. Gessa Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse Life Sciences 69 1 2001 101 111
61. 1 cannabinoid receptors British Journal of Pharmacology 134 1 2001 161 167
62. G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisogno, G. Rammes, M.G. Cascio, H. Hermann, J. Tang, C. Hofmann, W. Zieglgänsberger, V. Di Marzo, and B. Lutz The endogenous cannabinoid system controls extinction of aversive memories Nature 418 6897 2002 530 534
63. B. Martin, L.A. Stevenson, R.G. Pertwee, C.S. Breivogel, W. Williams, A. Mahadevan, and R.K. Razdan Agonists and silent antagonists in a series of cannabinoid sulfonamides Symposium on the Cannabinoids 2002 International Cannabinoid Research Society Burlington, Vermont 2
64. W.J. Martin, S.L. Patrick, P.O. Coffin, K. Tsou, and J.M. Walker An examination of the central sites of action of cannabinoid-induced antinociception in the rat Life Sciences 56 23-24 1995 2103 2109
65. N. Mascolo, A.A. Izzo, A. Ligresti, A. Costagliola, L. Pinto, M.G. Cascio, P. Maffia, A. Cecio, F. Capasso, and V. Di Marzo The endocannabinoid system and the molecular basis of paralytic ileus in mice FASEB Journal 16 2002 1973 1975
66. F. Massa, G. Marsicano, H. Hermann, A. Cannich, K. Monory, B.F. Cravatt, G.-L. Ferri, A. Sibaev, M. Storr, and B. Lutz The endogenous cannabinoid system protects against colonic inflammation Journal of Clinical Investigation 113 8 2004 1202 1209
67. S. Mato, A. Pazos, and E.M. Valdizán Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain European Journal of Pharmacology 443 1-3 2002 43 46
68. S.D. McAllister, G. Griffin, L.S. Satin, and M.E. Abood Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system Journal of Pharmacology and Experimental Therapeutics 291 2 1999 618 626
69. P.J. McLaughlin, K. Winston, L. Swezey, A. Wisniecki, J. Aberman, D.J. Tardif, A.J. Betz, K. Ishiwari, A. Makriyannis, and J.D. Salamone The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats Behavioural Pharmacology 14 8 2003 583 588
70. 1 cannabinoid receptor Biochemical Pharmacology 60 9 2000 1315 1323
71. J. Nie, and D.L. Lewis Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration Journal of Neuroscience 21 22 2001 8758 8764
72. T. Ohno-Shosaku, T. Maejima, and M. Kano Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals Neuron 29 3 2001 729 738
73. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity Molecular Pharmacology 54 6 1998 1064 1072
74. R.G. Pertwee Cannabinoid receptors and pain Progress in Neurobiology 63 5 2001 569 611
75. R.G. Pertwee Cannabinoids and the gastrointestinal tract Gut 48 6 2001 859 867
76. R.G. Pertwee Novel pharmacological targets for cannabinoids Current Neuropharmacology 2 2004 9 29
77. 1 receptors in mouse urinary bladder British Journal of Pharmacology 118 8 1996 2053 2058
78. 8-tetrahydrocannabinol in two isolated tissue preparations Eur. J. Pharmacol. 315 2 1996 195 201
79. 1 receptors in guinea-pig small intestine British Journal of Pharmacology 118 8 1996 2199 2205
80. R.G. Pertwee, and R.A. Ross Cannabinoid receptors and their ligands Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2-3 2002 101 121
81. R.G. Pertwee, R.A. Ross, S.J. Craib, and A. Thomas (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens European Journal of Pharmacology 456 1-3 2002 99 106
82. L. Pinto, R. Capasso, G. Di Carlo, and A.A. Izzo Endocannabinoids and the gut Prostaglandins Leukotrienes and Essential Fatty Acids 66 2-3 2002 333 341
83. L. Pinto, A.A. Izzo, M.G. Cascio, T. Bisogno, K. Hospodar-Scott, D.R. Brown, N. Mascolo, V. Di Marzo, and F. Capasso Endocannabinoids as physiological regulators of colonic propulsion in mice Gastroenterology 123 1 2002 227 234
84. M. Poncelet, J. Maruani, R. Calassi, and P. Soubrié Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice Neuroscience Letters 343 3 2003 216 218
85. 3H]CP55940 dissociation from mouse brain membranes Symposium on the Cannabinoids 2004 International Cannabinoid Research Society Burlington, Vermont 131
86. C. Ravinet Trillou, M. Arnone, C. Delgorge, N. Gonalons, P. Keane, J.-P. Maffrand, and P. Soubrié Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice American Journal of Physiology 284 2 2003 R345 R353
87. C. Ravinet Trillou, C. Delgorge, C. Menet, M. Arnone, and P. Soubrié CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity International Journal of Obesity 28 4 2004 640 648
88. R.A. Ross, H.C. Brockie, S.R. Fernando, B. Saha, R.K. Razdan, and R.G. Pertwee Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine British Journal of Pharmacology 125 6 1998 1345 1351
89. R.A. Ross, A.A. Coutts, S.M. McFarlane, S. Anavi-Goffer, A.J. Irving, R.G. Pertwee, D.J. MacEwan, and R.H. Scott Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception Neuropharmacology 40 2 2001 221 232
90. 8- tetrahydrocannabinol at cannabinoid receptors British Journal of Pharmacology 128 3 1999 735 743
91. T. Rubino, D. Viganò, E. Zagato, M. Sala, and D. Parolaro In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments Synapse 35 1 2000 8 14
92. 1 cannabinoid receptor Journal of Pharmacology and Experimental Therapeutics 306 1 2003 363 370
93. 1 receptors British Journal of Pharmacology 140 8 2003 1451 1459
94. E. Schlicker, and M. Kathmann Modulation of transmitter release via presynaptic cannabinoid receptors Trends in Pharmacological Sciences 22 11 2001 565 572
95. 1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release British Journal of Pharmacology 140 2 2003 323 328
96. E. Schlicker, J. Timm, and M. Göthert Cannabinoid receptor-mediated inhibition of dopamine release in the retina Naunyn-Schmiedeberg's Archives of Pharmacology 354 6 1996 791 795
97. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus Naunyn-Schmiedeberg's Archives of Pharmacology 356 5 1997 583 589
98. L.J. Sim-Selley, L.K. Brunk, and D.E. Selley Inhibitory effects of SR141716A on G-protein activation in rat brain European Journal of Pharmacology 414 2-3 2001 135 143
99. J.-P. Terranova, J.-J. Storme, N. Lafon, A. Pério, M. Rinaldi-Carmona, G. Le Fur, and P. Soubrié Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist SR 141716. Psychopharmacology 126 2 1996 165 172
100. T.J. Tersigni, and H.C. Rosenberg Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA Brain Research 733 2 1996 184 192
101. 1 receptor antagonist European Journal of Pharmacology 487 1-3 2004 213 221
102. 1 antagonist, O-2654, in two isolated nerve-smooth muscle preparations Symposium on the Cannabinoids 2004 International Cannabinoid Research Society Burlington, Vermont 100
103. C. Vásquez, and D.L. Lewis The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors Journal of Neuroscience 19 21 1999 9271 9280
104. 2+ currents in HEK293 cells Canadian Journal of Physiology and Pharmacology 81 5 2003 436 442
105. A.N.A. Verty, I.S. McGregor, and P.E. Mallet Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats Neuroscience Letters 354 3 2004 217 220
106. S.P. Vickers, L.J. Webster, A. Wyatt, C.T. Dourish, and G.A. Kennett Preferential effects of the cannabinoid CB, receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats Psychopharmacology 167 1 2003 103 111
107. J.M. Walker, S.M. Huang, N.M. Strangman, K. Tsou, and M.C. Sañudo-Peña Pain modulation by release of the endogenous cannabinoid anandamide Proceedings of the National Academy of Sciences of the United States of America 96 21 1999 12198 12203
108. R. White, and C.R. Hiley The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery British Journal of Pharmacology 125 4 1998 689 696
109. R.I. Wilson, and R.A. Nicoll Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 6828 2001 588 592
110. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sørgård, V. Di Marzo, D. Julius, and E.D. Högestätt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 6743 1999 452 457